Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oral biofilm microorganisms are diverse populations of bacteria (and some fungi and protozoa) that form organized, surface-associated communities known as **oral biofilms** or **dental plaque**[1][2][4]. These biofilms contain hundreds of species, including early colonizers such as *Streptococcus* spp., and late colonizers such as *Porphyromonas gingivalis*, *Tannerella forsythia*, and *Treponema denticola*, which interact within the extracellular polymeric substances (EPS) matrix comprising exopolysaccharides, proteins, lipids, inorganic ions, and extracellular DNA[1][4]. Biofilm formation is a multi-step process involving initial adhesion, colonization, maturation, and dispersion[3]. These microorganisms confer emergent properties such as increased tolerance to antimicrobials, immune modulation, and spatial heterogeneity, making oral biofilms resilient and challenging to treat[1][2]. Dysbiotic biofilms are implicated in both localized diseases—such as dental caries, periodontitis, and gingivitis—as well as systemic conditions including cardiovascular and neurodegenerative diseases[1]. Therapeutic approaches target the structure, function, and microbial communication systems—such as quorum sensing—within biofilms using antiseptics, antibiotics, natural products, and physical disruption, with considerable challenges around resistance and ecological balance[1][2][4].
Disruption of cell membranes; Inhibition of biofilm matrix synthesis; Inhibition of microbial metabolism; Inhibition of adhesion to surfaces; Quorum sensing inhibition; Enzymatic degradation of exopolysaccharides
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral biofilm microorganism.